Stocks · Healthcare · Drug Manufacturers - Specialty & Generic
Indivior Pharmaceuticals Inc INDV
$35.71 +0.93% Close, Oct 2, 2026 · NASDAQ · Market cap $4.46B
High qualityInexpensive vs sectorLow risk
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $2.79, up 179.0% year over year.
- Operating margin widened to 38.9% from 20.3% a year earlier.
- At 12.8× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 42%
- EPS growth (TTM, YoY)Top 9%
- FCF growth (TTM, YoY)Bottom 8%
- Revenue growth, 3-year CAGRTop 47%
- Revenue growth accelerationTop 22%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 1%
- Gross marginTop 26%
- Operating marginTop 4%
- Cash conversion (OCF / net income)Bottom 6%
- Accruals (lower is better)Bottom 3%
- Net debt / EBITDA (lower is better)Top 44%
- Interest coverTop 8%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 5%
- Free-cash-flow yieldTop 44%
- EBITDA / enterprise valueTop 11%
- Sales / enterprise valueTop 44%
- P/E vs own 5-year history (lower is better)Top 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 34%
- 6-month returnTop 41%
- 1-year return vs S&P 500Top 26%
- Distance from 52-week highTop 25%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 12%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 37%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 10%
- Maximum drawdown, 3 yearsTop 46%
- Beta vs S&P 500 (lower is better)Top 26%
- Net debt / EBITDA (lower is better)Top 44%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 10.2% | 13.5% | ↑ |
| EPS growth (YoY) | 1314.3% | 179.0% | ↓ |
| Gross margin | 84.0% | 83.9% | ↓ |
| Operating margin | 20.3% | 38.9% | ↑ |
| FCF margin | 15.7% | -8.3% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 13.5% | 10.2% | ↑ | Top 42% |
| EPS growth (TTM, YoY) | 179.0% | 1314.3% | ↓ | Top 9% |
| Gross margin | 83.9% | 84.0% | ↓ | Top 26% |
| Operating margin | 38.9% | 20.3% | ↑ | Top 4% |
| Net margin | 26.7% | 10.9% | ↑ | — |
| Free-cash-flow margin | -8.3% | 15.7% | ↓ | — |
| Return on invested capital | 125.1% | — | Top 1% | |
| Revenue growth, 3-year CAGR | 11.2% | — | Top 47% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- -0.11×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 32.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +6.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.66×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 19.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 7.25%
- Shareholder yield
- 7.25%
- Share count change, 1 year
- +4.3%
- Share count change, 3-year CAGR
- -3.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +49.5%
- Average 2-day reaction, last 8
- +3.9%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $48.00
- Target vs current price
- +34.4%
- Analysts with a rating
- 4
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | +32.3% | -6.6% | -3.0% | -12.8% | — |
| Apr 30, 2026 | +50.0% | +7.7% | +18.9% | +7.2% | +17.2% |
| Feb 26, 2026 | +26.2% | +0.2% | -4.4% | -10.0% | +11.4% |
| Oct 30, 2025 | +89.5% | +15.4% | +27.0% | +32.6% | +37.6% |
| Jul 31, 2025 | +96.2% | +16.1% | +26.4% | +40.0% | +45.3% |
| Apr 24, 2025 | +86.4% | +13.9% | +21.8% | +19.5% | +65.1% |
| Feb 20, 2025 | +0.0% | -17.6% | -21.4% | -8.8% | +1.5% |
| Oct 24, 2024 | +74.2% | +2.5% | +8.6% | +23.6% | +41.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | $1.15 | $0.87 | +32.3% | $343.0M |
| Apr 30, 2026 | $0.96 | $0.64 | +50.0% | $317.0M |
| Feb 26, 2026 | $0.82 | $0.65 | +26.2% | $358.0M |
| Oct 30, 2025 | $0.72 | $0.38 | +89.5% | $314.0M |
| Jul 31, 2025 | $0.51 | $0.26 | +96.2% | $302.0M |
| Apr 24, 2025 | $0.41 | $0.22 | +86.4% | $266.0M |
| Feb 20, 2025 | $0.32 | $0.32 | +0.0% | $299.0M |
| Oct 24, 2024 | $0.54 | $0.31 | +74.2% | $307.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 12.8× | 22.4× | 0th | Top 5% |
| P/E (forward) | 8.5× | — | — | — |
| EV / EBITDA | 11.0× | — | — | Top 11% |
| EV / Sales | 3.56× | — | — | Top 44% |
| Free-cash-flow yield | -2.49% | — | — | Top 44% |
| Earnings yield | 7.81% | — | — | Top 5% |
P/E over the past five years
Range 13.4× – 101.5× since Sep 30, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +52.2%
- Earnings per share growth (TTM)
- +179.0%
- Change in P/E multiple
- -33.7%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -5.4%
- 200-day average slope (20 days)
- +0.4%
- Distance from 50-day average
- -3.0%
- Distance from 200-day average
- -0.1%
- RSI (14)
- 48.3
- Relative volume
- 0.86×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 30.3%
- Volatility vs own 5-year history
- 4th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.68
- Correlation with S&P 500
- 0.20
- Current drawdown from 1-year high
- -14.6%
- Maximum drawdown, 3 years
- -67.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 18, 2022 | Nov 23, 2022 | -85.5% | 153 days | 13 days (Dec 13, 2022) |
| Jul 25, 2023 | Oct 11, 2024 | -69.9% | 307 days | 224 days (Sep 5, 2025) |
| Jan 27, 2023 | Mar 28, 2023 | -33.5% | 41 days | 81 days (Jul 25, 2023) |
| Nov 18, 2020 | Dec 21, 2020 | -29.0% | 22 days | 20 days (Jan 21, 2021) |
| Dec 8, 2025 | Mar 30, 2026 | -21.4% | 76 days | 22 days (Apr 30, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $4.46B
- P/E (TTM)
- 12.8
- EPS, diluted (TTM)
- $2.79
- Revenue (TTM)
- $1.33B
- Dividend yield
- 22.77%
- 52-week range
- $22.56 – $42.81
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $791.0M | $901.0M | $1.09B | $1.19B | $1.24B |
| Gross profit | $664.0M | $750.0M | $919.0M | $957.0M | $993.0M |
| Operating income | $213.0M | -$81.0M | -$156.0M | $32.0M | $265.0M |
| Net income | $205.0M | -$44.0M | -$129.0M | $2.0M | $210.0M |
| EPS (diluted) | $1.31 | -$0.37 | -$0.91 | $0.02 | $1.64 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $307.0M | $299.0M | $266.0M | $302.0M | $314.0M | $358.0M | $317.0M | $343.0M |
| Net income | $4.0M | $59.0M | $47.0M | $18.0M | $42.0M | $102.0M | $89.0M | $122.0M |
| EPS (diluted) | $0.03 | $0.45 | $0.38 | $0.14 | $0.33 | $0.82 | $0.69 | $0.95 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $353.0M | -$4.0M | -$300.0M | $36.0M | -$27.0M |
| Capital expenditure | -$34.0M | -$5.0M | -$53.0M | -$31.0M | -$67.0M |
| Free cash flow | $319.0M | -$9.0M | -$353.0M | $5.0M | -$94.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$100.0M | -$98.0M | -$52.0M | -$192.0M | -$14.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $222.0M
- Total assets
- $1.23B
- Total liabilities
- $1.44B
- Total debt
- $509.0M
- Net debt
- $287.0M
- Shareholders’ equity
- -$208.0M
As of Jun 30, 2026 (filed Aug 3, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Oct 30, 2026 | $8.13 | Nov 6, 2026 |
| Jun 16, 2016 | $0.10 | Jul 29, 2016 |
| Sep 17, 2015 | $0.03 | Oct 23, 2015 |
Short interest
- Shares sold short
- 11,172,005
- Days to cover
- 5.70
- Change vs previous report
- -1.1%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Oct 10, 2022
- 1-for-5